Last updated 2 years ago

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

52 patients around the world
Available in Mexico, United States
Kartos Therapeutics, Inc.
4Research sites
52Patients around the world
This study is for people with
Myeloproliferative syndromes
Myelofibrosis
Polycythemia vera
Essential thrombocythemia
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Sociedad de Metabolismo y Corazón S.C
Recruiting
Alacio Pérez 661, Ricardo Flores Magón, Veracruz
Centro de Investigación Clínica de Oaxaca - Oaxaca
Centro de Investigación Clínica de Oaxaca - Oaxaca
Recruiting
Carretera a San Luis Beltrán No.112. Col. Jardín, Oaxaca
Centro de Investigación Médica Aguascalientes - CIMA
Centro de Investigación Médica Aguascalientes - CIMA
Recruiting
Av Independencia 2130, Trojes de Alonso, Aguascalientes
Unidad de Investigación CIMA SC
Recruiting
PASCUAL OROZCO 2125, COLONIA MAGISTERIAL, Chihuahua, Chihuahua, Código Postal 31200
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy